ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

NPTH Enpath Medical (MM)

0.00
0.00 (0.00%)
After Hours
Last Updated: -
Delayed by 15 minutes
Share Name Share Symbol Market Type
Enpath Medical (MM) NASDAQ:NPTH NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0 -

Enpath Medical Announces Third Quarter 2005 Earnings Release and Conference Call Date

10/10/2005 1:00pm

PR Newswire (US)


Enpath (NASDAQ:NPTH)
Historical Stock Chart


From Jun 2019 to Jun 2024

Click Here for more Enpath Charts.
MINNEAPOLIS, Oct. 10 /PRNewswire-FirstCall/ -- Enpath Medical, Inc. (NASDAQ:NPTH) announced today that it will release its third quarter 2005 financial results before the market opens on Thursday, October 20, 2005. The management team of Enpath Medical will host a conference call to discuss the results beginning at 1:30 P.M. Central Time, also on Thursday, October 20, 2005. To participate, please call 800-257-6607 for domestic callers and 303-262-2125 for international callers. A recording of the conference call will be available approximately one hour after the conclusion of the call and will be accessible for seven days. To access the replay, please dial 1-800-405-2236 for domestic callers and 303- 590-3000 for international callers; please reference the passcode 11041409#. The conference call will also be webcast live on the company's web site, http://www.enpathmed.com/ , and may be accessed by clicking on the 3rd Quarter 2005 Earnings Call icon. An audio replay will be archived on the Enpath website for one year. About Enpath Medical Enpath Medical, Inc., headquartered in Plymouth, Minnesota, is a leader in the design, development, manufacture and marketing of percutaneous delivery systems and stimulation leads technologies. Its products include venous vessel introducers, epicardial and endocardial stimulation leads, safety needles and other products for use in pacemaker, defibrillator, catheter and infusion port procedures as well as neuromodulation and hearing restoration markets. Its products are sold worldwide through partnering relationships with other medical device companies. DATASOURCE: Enpath Medical, Inc. CONTACT: Investors, Doug Sherk, Jennifer Beugelmans of EVC Group, both at +1-415-896-6820, Media, Steve DiMattia of EVC Group, +1-646-277-8706 Web site: http://www.enpathmed.com/

Copyright

1 Year Enpath Chart

1 Year Enpath Chart

1 Month Enpath Chart

1 Month Enpath Chart